The effects of levosimendan in patients undergoing transcatheter aortic valve replacement- a retrospective analysis

Background: Aortic stenosis (AS) increases left ventricular afterload, leading to cardiac damage and heart failure (HF). Transcatheter aortic valve replacement (TAVR) is an effective therapy for AS. No inotropic agents including levosimendan have been evaluated in patients undergoing TAVR. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhenyan, Meng, Zhen, Song, Guangyuan, Wang, Chunrong, Shi, Sheng, Zhao, Jie, Zhang, Hongliang, Wang, Moyang, Niu, Guannan, Zhou, Zheng, Wang, Jianhui, Wu, Yongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669067/
https://www.ncbi.nlm.nih.gov/pubmed/36408223
http://dx.doi.org/10.3389/fphar.2022.969088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669067/
https://www.ncbi.nlm.nih.gov/pubmed/36408223
http://dx.doi.org/10.3389/fphar.2022.969088

Ejemplares similares